Tumor Volume of Growth Hormone-Secreting Pituitary Adenomas during Treatment with Pegvisomant: A Prospective Multicenter Study-Reference-Cited by-同舟云学术

Tumor Volume of Growth Hormone-Secreting Pituitary Adenomas during Treatment with Pegvisomant: A Prospective Multicenter Study

Published:2010-02-01 Issue:2 Volume:95 Page:552-558
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Buhk Jan-Hendrik¹²,Jung Sabine¹,Psychogios Marios Nikos¹,Göricke Sophia³,Hartz Sabine⁴,Schulz-Heise Susanne⁵,Klingebiel Randolf⁶,Forsting Michael³,Brückmann Hartmut⁴,Dörfler Arnd⁵,Jordan Martina⁷,Buchfelder Michael⁸,Knauth Michael¹

Affiliation:

1. Department of Neuroradiology (J.-H.B., S.J., M.N.P., M.K.), University of Goettingen, D-37075 Goettingen, Germany

2. Department of Diagnostic and Interventional Radiology (J.-H.B.), University of Hamburg, D-20246 Hamburg, Germany

3. Department of Diagnostic and Interventional Radiology (S.G., M.F.), University of Essen, D-45147 Essen, Germany

4. Department of Neuroradiology (S.H., H.B.), University of Munich, D-81377 Munich, Germany

5. Departments of Neuroradiology (S.S.-H., A.D.), University of Erlangen-Nuremberg, D-91054 Erlangen Germany

6. Department of Neuroradiology (R.K.), Charité, Free University of Berlin, D-10117 Berlin, Germany

7. ClinSupport, Clinical Trials and Marketing Support (M.J.), Erlangen, Germany

8. Neurosurgery (M.B.), University of Erlangen-Nuremberg, D-91054 Erlangen Germany

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/95/2/552/9065287/jcem0552.pdf

Reference29 articles.

1. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group;Vance;Arch Intern Med,1991

2. Treatment of acromegaly with dopamine agonists;Jaffe;Endocrinol Metab Clin North Am,1992

3. Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients—a clinical research center study;Newman;J Clin Endocrinol Metab,1995

4. Cabergoline in the treatment of acromegaly: a study in 64 patients;Abs;J Clin Endocrinol Metab,1998

5. Medical progress: acromegaly;Melmed;N Engl J Med,2006

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical treatment of acromegaly – When the tumor size matters: A narrative review;Growth Hormone & IGF Research;2024-10

2. Efficacy and Safety of Pegvisomant in the Treatment of Acromegaly;Archives of Medical Research;2023-12

3. Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis;Frontiers in Endocrinology;2022-07-01

4. More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY;European Journal of Endocrinology;2021-10-01

5. Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study;Endocrine;2020-09-28